EATG » News

Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living with HIV/AIDS, was recently updated. This is a joint collaboration…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together with the report we are also launching a set of video…

The EU Civil Society Forum on HIV/AIDS, TB and viral hepatitis reacts to the relevant Commission Staff Working Document

GASTEIN - On 4 October -on the occasion of the European Health Forum discussion on Reaching the SDG targets on Health by 2030 - Actions needed to end AIDS & TB…

#JusticeForZak: sign the petition, join the campaign

On Friday 21 September, Zak Kostopoulos, died as a consequence of brutal beatings in Athens Greece. We call all relevant Greek authorities for a swift, thorough, independent and impartial investigation into…

We call on the authorities to ensure that justice for Zak Kostopoulos is done

On Friday 21 September, Zak Kostopoulos, died as a consequence of brutal beatings in Athens Greece. Zak was an HIV+, sex positive, queer, human rights’ activist and defender, also raising…

EATG General Assembly 2018 (Vilnius, 27-30 September)

The European AIDS Treatment Group is holding its annual General Assembly in Vilnius, Lithuania over the next four days. More than 75 members and the staff of EATG are gathering…

The Value of Health: Improving Outcomes final report was launched

Today, the The Value of Health: Improving Outcomes multi-stakeholder initiative launched its final report at the European Parliament. European AIDS Treatment Group's chair, Nikos Dedes, highlighted the critical importance of…

The European AIDS Treatment Group is looking for a Financial Assistant

Type of contract: Half-time, temporary position with possibility for extension Location: Brussels, Belgium Reporting to: Executive Director Start date: As soon as possible The European AIDS Treatment Group is looking…

The European AIDS Treatment Group is looking for an Executive Director

Type of contract: Full-time, permanent contract Location: Brussels, Belgium Reporting to: Board of Directors Start date: As soon as possible in the range of October-December 2018 The European AIDS Treatment…

2nd Hep-C Community Summit: We are more than just patients

The European AIDS Treatment Group participates in the 2nd Hep-C Community Summit that takes place on the 18th of September in Lisbon. Organised by Correlation European Harm Reduction Network, the summit will…

Webinar: Patient Engagement on Medicines Research & Development

Join us for a webinar about patient engagement in the process of research and development of medicines on Thursday, September 6 from 18:00 to 19:15 CET.   Four European patient…

Open letter: UN General Assembly High Level Meeting on the fight against Tuberculosis

Few weeks before the UN General Assembly High Level Meeting on the fight against Tuberculosis, the EATG issues an open letter: 'As negotiations on the final declaration are now being…

ESTICOM: First from a series of community reports from EMIS 2017 is now online

A week ago the EATG co-chaired the satellite symposium "European surveys and trainings to improve MSM community health (ESTICOM)" at the 22nd International AIDS conference.  During this session we had…

The EATG welcomes the European Court of Justice decision to invalidate the patent extension of Truvada

Amsterdam, 26 July 2018   The European AIDS Treatment Group welcomes the landmark decision of the European Court of Justice confirming the invalidity of the patent extension (Supplementary Protection Certificate)…

EATG at the 22nd International AIDS conference: Catch up with the evidence and give our communities the services we need

Amsterdam, 23 July 2018   As an organisation led by people living with HIV/AIDS across Europe and Central Asia, working together with the several affected communities in the last 25…

AIDS 2018: Addressing research gaps identified by women living with HIV in Europe and Central Asia

We are pleased to invite you to join a side-meeting at the AIDS 2018 conference that will bring together community, clinicians and researchers to discuss research gaps related to women…

AIDS 2018: The programme and the presentations of the European Civil Society Forum booth in the Global Village

The EATG and AIDS Action Europe are co-hosting the European Civil Society Forum (booth 618) at the Global Village of the 22nd International AIDS Conference in Amsterdam. Organisations and activists…

Ageing with HIV conference outcomes: read watch and register to discuss

The EATG organised a conference titled ‘New challenges and unmet needs of people living and ageing with HIV/AIDS aged 18-50, Quality of Life and Preventive Healthcare’ from 3 to 6…

EATG’s new term as a member of the Civil Society Forum on Drugs (2018-2021)

This week the European AIDS Treatment Group participated in the first meeting of the new 3-year term of the Civil Society Forum on Drugs that took place in Brussels. The CSFD…

Guideline updates for the treatment of adolescents and adults with HIV

The availability of more treatment options for HIV has made management of infections easier than ever before. With over 45 individual and fixed-dose combination antiretroviral agents approved by the US…

New light shed on HIV-1 reservoir reductions after stem cell transplant

Several factors underlie a profound reduction in the HIV-1 reservoir in patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT) for hematologic disease, researchers report. Previous studies have found substantial…

Drop in Australia HIV sparks call for greater drug roll-out

HIV transmission rates among gay and bisexual men fell by almost a third in the Australian state of New South Wales following the wide-scale introduction of a daily anti-HIV drug,…

Mark Josef Rapa: HIV does not discriminate

I refer to the reply by the Equality Ministry ‘LGBTIQ action plan’ (September 20) to my comments in ‘HIV treatment in Malta archaic, activist warns’. In its reply, the government…

Pain highly prevalent among people with HIV and has a major impact on mental health, quality of life, employment and use of healthcare

Pain is very common among people living with HIV (PLWH) and has a major impact on quality of life and use of healthcare resources, investigators from the UK and Ireland…

Combined treatment for smoking cessation, anxiety and depression more effective than smoking cessation alone

A randomised control trial published in The Journal of Acquired Immune Deficiency Syndromes by researchers in Boston found that an integrated cognitive-behavioural treatment approach aiming to target smoking cessation as…

Low-dose methotrexate: No effect on endothelial function in patients treated for HIV

For patients with treated HIV who have or who are at an increased risk for atherosclerotic cardiovascular disease (ASCVD), low-dose methotrexate (LDMTX) does not significantly affect endothelial function or inflammatory…

LGBTQ History Month: The early days of America’s AIDS crisis

From Reagan’s press secretary laughing about the AIDS crisis to the activist group ACT UP shutting down the FDA, this story looks back at the early days of the epidemic.…

VBI Vaccines completes vaccination in PROTECT Phase 3 clinical study for Sci-B-Vac® hepatitis B vaccine

-- Vaccination complete in 1,537 subjects in PROTECT Phase 3 study -- No vaccine-related adverse events have been observed to-date -- Top-line data expected mid-2019 October 16, 2018: VBI Vaccines…

The sleeping giant: the danger of neglecting latent TB infection

The European Centre for Disease Prevention and Control (ECDC) has published comprehensive guidance on the management of latent tuberculosis infection (LTBI) targeted for European Union/European Economic Area (EU/EEA) countries. October…

Germany: taking a human-rights based approach to injecting drug use

People who inject drugs often have one or more associated health issues. Drug use and mental health issues often coexist and drug use can increase the risk of contracting infections.…

No, the HPV vaccine does not lead to riskier sexual behaviors in girls

Many parents of adolescent girls have resisted the human papillomavirus vaccine for fear it will have negative behavioral consequences. The human papillomavirus (HPV) vaccine is not associated with an increase…

Majority of US young adults who use drugs are not tested for hepatitis C or HIV

Only about a third of adolescents and young adults diagnosed with opioid use disorder in the United States are screened for hepatitis C virus (HCV) or HIV, even though injection…

Rapid initiation of HIV care: Assessing safety and efficacy

Study finds no link between neurocognitive impairment, depression in HIV patients

SAN FRANCISCO — Findings from a retrospective study presented at IDWeek showed no association between neurocognitive impairment and depression in patients with HIV. “I was talking to mentor, Zsofi Szep…

Wide range of views about switching to weekly, monthly or biannual ART

Two-thirds of people taking combination antiretroviral therapy (cART) would be interested in switching to a once-weekly oral regimen should it become available, according to American research published in Open Forum…

Anal HPV-16 infection significantly more common in MSM, especially those living with HIV

Anal infection with HPV-16, the type of human papillomavirus most strongly associated with anal cancer, is most common in HIV-positive gay men, similar between HIV-negative gay men and HIV-positive heterosexual…

Viral suppression in children on ART identified via quantitative HIV antibody levels

For children receiving antiretroviral therapy (ART), HIV-1-specific antibody levels can be useful markers for identifying those with viral suppression or low residual cell-associated HIV-1 DNA levels, according to research published…

HIV-positive infants are at high risk for acquiring congenital cytomegalovirus infection

FINDINGS Infants born to HIV-positive mothers had high rates of congenital cytomegalovirus, or CMV. Infants who also were infected before birth by the virus that causes AIDS were especially prone…

Internet-based intervention can reduce depression in people living with HIV

A guided internet-based intervention can effectively reduce depressive symptoms for people living with HIV, according to results published in Lancet HIV. The study included participants from 23 HIV treatment centers in…